Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 17
2003 31
2004 18
2005 50
2006 47
2007 73
2008 79
2009 98
2010 101
2011 102
2012 123
2013 169
2014 200
2015 311
2016 271
2017 298
2018 319
2019 372
2020 395
2021 449
2022 521
2023 517
2024 508
2025 581
2026 160

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,144 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.
Liang YL, Liu X, Shen LF, Hu GY, Zou GR, Zhang N, Chen CB, Chen XZ, Zhu XD, Yuan YW, Yang KY, Jin F, Hu WH, Xie FY, Huang Y, Han F, Tang LL, Mao YP, Lu LX, Sun R, He YX, Zhou YY, Long GX, Tang J, Chen LS, Zong JF, Jin T, Li L, Lin J, Huang J, Gong XY, Zhou GQ, Chen L, Li WF, Chen YP, Xu C, Lin L, Huang SH, Huang SW, Wang YQ, Huang CL, Feng HX, Hou M, Chen CH, Zheng SF, Li YQ, Hong SB, Jie YS, Li H, Yun JP, Zang SB, Liu SR, Lin QG, Li HJ, Tian L, Liu LZ, Zhao HY, Li JB, Lin AH, Liu N, Zhang Y, Guo R, Ma J, Sun Y. Liang YL, et al. Among authors: ma j. JAMA. 2025 May 13;333(18):1589-1598. doi: 10.1001/jama.2025.1132. JAMA. 2025. PMID: 40079940 Free PMC article. Clinical Trial.
A call to action: the second Lancet Commission on adolescent health and wellbeing.
Baird S, Choonara S, Azzopardi PS, Banati P, Bessant J, Biermann O, Capon A, Claeson M, Collins PY, De Wet-Billings N, Dogra S, Dong Y, Francis KL, Gebrekristos LT, Groves AK, Hay SI, Imbago-Jácome D, Jenkins AP, Kabiru CW, Kennedy EC, Li L, Lu C, Ma J, McGovern T, Mensa-Kwao A, Mojola SA, Nagata JM, Olumide AO, Omigbodun O, O'Sullivan M, Prost A, Requejo JH, Shawar YR, Shiffman J, Silverman A, Song Y, Swartz S, Tamambang R, Urdal H, Ward JL, Patton GC, Sawyer SM, Ezeh A, Viner RM. Baird S, et al. Among authors: ma j. Lancet. 2025 May 31;405(10493):1945-2022. doi: 10.1016/S0140-6736(25)00503-3. Epub 2025 May 20. Lancet. 2025. PMID: 40409329 Review. No abstract available.
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial.
DIAMOND Study Group; Xu C, Liang XY, Huang XQ, Jin F, Yang KY, Hu GY, Zhu XD, Wang Y, Huang Y, Zhang N, Hu DS, Guo L, Zou GR, Chen XZ, Xiao SW, Li JG, Shen LF, Li YY, Huang J, Long GX, Li L, Huang L, She LJ, Wu Y, Zeng WH, Qiang MY, Liu WX, Su Y, Tang LL, Xie FY, Han F, Lu LX, Xiang YQ, Mao YP, Li WF, Liu X, Yang Q, Zhou GQ, Guo R, Ouyang PY, Wang XH, Chen L, Liu LT, Lin L, Li JB, Lin AH, Zhao HY, Hong SB, Jie YS, Huang HL, Tang XH, Zeng YC, Yun JP, Zang SB, Du ZM, Ye ZL, Liu LZ, Tian L, Li HJ, Peng YL, Liu N, Li YQ, Liang YL, Wei HM, Chen YP, Zhang Y, Du XJ, Lv JW, Sun Y, Ma J. DIAMOND Study Group, et al. Among authors: ma j. JAMA. 2025 Sep 16;334(11):973-983. doi: 10.1001/jama.2025.13205. JAMA. 2025. PMID: 40839372 Free PMC article. Clinical Trial.
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).
Lin SJ, Guo QJ, Liu Q, Ng WT, Ahn YC, AlHussain H, Chan AW, Chow J, Chua MLK, Corry J, Han F, Grégoire V, Harrington KJ, Hu CS, Jensen K, Langendijk JA, Le QT, Lee NY, Lee V, Lin JC, Ma J, Mendenhall WM, O'Sullivan B, Ozyar E, Rosenthal DI, Tao YG, Wang RS, Wee J, Xu ZY, Yi JL, Yom SS, Fan DM, Mai HQ, Pan JJ, Lee AWM. Lin SJ, et al. Among authors: ma j. Int J Radiat Oncol Biol Phys. 2025 Oct 1;123(2):415-431. doi: 10.1016/j.ijrobp.2025.05.019. Epub 2025 May 24. Int J Radiat Oncol Biol Phys. 2025. PMID: 40419028 Free article.
Tissue-resident microbiota signature in nasopharyngeal carcinoma.
Tan XR, Qiao H, Li YQ, Jiang W, Huang SY, Gong S, Li WF, Tang LL, Zhou GQ, Liang YL, Li H, He QM, Bai JW, Ye ML, Wang JY, Huang SW, Li JY, Gan CQ, Li YQ, Zhao Y, Sun Y, Ma J, Liu N. Tan XR, et al. Among authors: ma j. Microbiome. 2025 May 17;13(1):125. doi: 10.1186/s40168-025-02114-w. Microbiome. 2025. PMID: 40382629 Free PMC article.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Petit C, Lee A, Ma J, Lacas B, Ng WT, Chan ATC, Hong RL, Chen MY, Chen L, Li WF, Huang PY, Tan T, Ngan RKC, Zhu G, Mai HQ, Hui EP, Fountzilas G, Zhang L, Carmel A, Kwong DLW, Moon J, Bourhis J, Auperin A, Pignon JP, Blanchard P; MAC-NPC Collaborative Group. Petit C, et al. Among authors: ma j. Lancet Oncol. 2023 Jun;24(6):611-623. doi: 10.1016/S1470-2045(23)00163-8. Lancet Oncol. 2023. PMID: 37269842
5,144 results